— Know what they know.
Not Investment Advice
Also trades as: 0R29.L (LSE) · $vol 2M · ISRG.TO (TSX) · $vol 0M

ISRG NASDAQ

Intuitive Surgical, Inc.
1W: +4.3% 1M: +11.5% 3M: +24.8% YTD: -19.6% 1Y: -18.1% 3Y: +65.2% 5Y: +35.9%
$445.88
-5.75 (-1.27%)
After Hours: $445.50 (-0.38, -0.09%)
Weekly Expected Move ±4.1%
$415 $434 $452 $471 $489
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Buy · Power 73 · $159.6B mcap · 345M float · 0.824% daily turnover · Short 55% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z 31.52.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
39.5 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 22.6%  ·  5Y Avg: 19.9%
Cost Advantage
30
Intangibles
26
Switching Cost
12
Network Effect
65
Scale ★
95
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ISRG has No discernible competitive edge (39.5/100). The business operates without significant structural advantages. The primary source of advantage is Efficient Scale. ROIC of 22.6% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$480
Low
$510
Avg Target
$550
High
Based on 7 analysts since Oct 20, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 40Hold: 12Sell: 5Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$474.73
Analysts13
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-21 Leerink Partners Mike Kratky $454 $503 +49 +18.8% $423.35
2026-10-21 RBC Capital — $600 $550 -50 +31.3% $418.86
2026-10-21 Oppenheimer Suraj Kalia Initiated $500 — +14.2% $438.00
2026-10-21 Robert W. Baird — $500 $550 +50 +25.6% $438.00
2026-10-21 Wells Fargo Larry Biegelsen $487 $486 -1 +11.0% $438.00
2026-10-21 Barclays — $485 $500 +15 +14.2% $438.00
2026-10-21 Raymond James Jayson Bedford $483 $480 -3 +9.6% $438.00
2026-10-13 Mizuho Securities — $400 $415 +15 -3.0% $427.64
2026-10-12 BTIG — $469 $454 -15 +6.8% $425.10
2026-10-06 Barclays — $651 $485 -166 +19.8% $404.76
2026-07-30 HSBC — Initiated $391 — +10.7% $353.10
2026-07-28 UBS Priya Sachdeva $570 $500 -70 +40.1% $356.83
2026-07-27 Piper Sandler — $470 $357 -113 -0.3% $358.35
2026-07-17 Raymond James Jayson Bedford $603 $483 -120 +35.4% $356.77
2026-07-17 Mizuho Securities — $500 $400 -100 -0.6% $402.33
2026-07-17 BTIG — $512 $469 -43 +16.6% $402.33
2026-07-17 Piper Sandler Adam Maeder $580 $470 -110 +16.8% $402.33
2026-07-17 Stifel Nicolaus Rick Wise $670 $550 -120 +36.7% $402.33
2026-07-17 Robert W. Baird — $655 $500 -155 +24.3% $402.33
2026-07-17 Wells Fargo Larry Biegelsen $466 $487 +21 +21.0% $402.33
2026-07-17 Leerink Partners Mike Kratky Initiated $454 — +12.8% $402.33
2026-07-16 Truist Financial — $580 $510 -70 +27.7% $399.34
2026-07-15 Mizuho Securities — $525 $500 -25 +31.8% $379.50
2026-07-14 Stifel Nicolaus Rick Wise $525 $670 +145 +64.6% $407.12
2026-07-13 RBC Capital — $650 $600 -50 +46.7% $408.89
2026-07-13 BTIG — $616 $512 -104 +25.9% $406.78
2026-07-08 BMO Capital — Initiated $518 — +24.8% $415.10
2026-07-06 Evercore ISI — $550 $430 -120 +1.9% $422.04
2026-06-02 Piper Sandler Adam Maeder $620 $580 -40 +45.9% $397.61
2026-05-27 Goldman Sachs — $714 $558 -156 +27.8% $436.64
2026-04-23 Barclays — $712 $651 -61 +34.6% $483.62
2026-04-15 Truist Financial — $650 $580 -70 +22.9% $472.02
2026-04-13 Mizuho Securities — $575 $525 -50 +16.5% $450.47
2026-02-24 UBS — $600 $570 -30 +16.1% $491.00
2026-01-26 Barclays — $686 $712 +26 +35.9% $523.99
2026-01-23 Evercore ISI Vijay Kumar $580 $550 -30 +5.0% $523.60
2026-01-23 Piper Sandler — $610 $620 +10 +17.9% $525.81
2026-01-23 Bernstein — $740 $750 +10 +42.6% $525.81
2026-01-09 Bernstein — $685 $740 +55 +26.5% $585.08
2026-01-09 Goldman Sachs — $604 $714 +110 +22.0% $585.08
2026-01-07 BTIG — $589 $616 +27 +3.9% $592.85
2026-01-07 Barclays — $314 $686 +372 +15.7% $592.85
2026-01-05 Evercore ISI — $490 $580 +90 +2.5% $565.96
2025-12-18 Truist Financial — $620 $650 +30 +14.9% $565.57
2025-12-17 RBC Capital Shagun Singh $625 $650 +25 +17.2% $554.58
2025-10-23 UBS — $529 $600 +71 +13.8% $527.03
2025-10-22 Mizuho Securities Anthony Petrone $550 $575 +25 +24.3% $462.74
2025-10-22 Truist Financial Richard Newitter $525 $620 +95 +34.0% $462.74
2025-10-22 RBC Capital — $555 $625 +70 +35.1% $462.74
2025-10-22 Raymond James — $330 $603 +273 +30.3% $462.74

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 27, 2026
DCF
3
ROE
5
ROA
5
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ISRG receives an overall rating of B. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-23 B- B
2026-10-01 B B-
2026-09-02 B- B
2026-07-01 B B-
2026-05-04 B- B
2026-04-21 B B-
2026-04-01 B+ B
2026-02-11 C- B+
2026-01-23 B- C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 76 Grade A+
Profitability
75
Balance Sheet
98
Earnings Quality
73
Growth
61
Value
30
Momentum
87
Safety
100
Cash Flow
92
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ISRG scores highest in Safety (100/100) and lowest in Value (30/100). An overall grade of A+ places ISRG among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
28.44
Safe Zone
Piotroski F-Score
7/9
✓ ✓ ✓ ✓ ✗ ✗ ✓ ✓ ✓
Beneish M-Score
-2.68
Unlikely Manipulator
Ohlson O-Score
-13.06
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA
Score: 89.0/100
Trend: Stable
Earnings Quality
75/100
OCF/NI: 1.38x
Accruals: -5.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ISRG scores 28.44, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ISRG scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ISRG's score of -2.68 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ISRG's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ISRG receives an estimated rating of AA (score: 89.0/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ISRG's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
53.17x
PEG
6.01x
P/S
13.58x
P/B
9.71x
P/FCF
39.74x
P/OCF
34.96x
EV/EBITDA
33.15x
EV/Revenue
12.00x
EV/EBIT
39.26x
EV/FCF
38.61x
Earnings Yield
2.07%
FCF Yield
2.52%
Shareholder Yield
3.23%
Graham Number
$92.76
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 53.2x earnings, ISRG is priced for high growth expectations. Graham's intrinsic value formula yields $92.76 per share, 387% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.817
NI / EBT
×
Interest Burden
1.023
EBT / EBIT
×
EBIT Margin
0.306
EBIT / Rev
×
Asset Turnover
0.598
Rev / Assets
×
Equity Multiplier
1.176
Assets / Equity
=
ROE
18.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ISRG's ROE of 18.0% is driven by Asset Turnover (0.598), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$323.81
Price/Value
1.26x
Margin of Safety
-25.58%
Premium
25.58%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ISRG's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. ISRG actually compounded EPS at 25.7% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. ISRG trades at a 26% premium to its adjusted intrinsic value of $323.81, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 53.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$445.88
Median 1Y
$480.09
5th Pctile
$261.33
95th Pctile
$882.83
Ann. Volatility
35.2%
Analyst Target
$474.73
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
David J. Rosa
Chief Executive Officer
$858,750 $18,674,872 $20,997,480
Gary S. Guthart,
Ph.D. Executive Chair of the Board of Directors
$866,250 $15,954,662 $18,094,937
Jamie E. Samath
Executive Vice President, Chief Financial Officer and Enterprise Technology Leader
$683,000 $6,914,229 $8,396,045
Henry L. Charlton
Executive Vice President and Chief Commercial and Marketing Officer
$670,000 $4,786,863 $6,240,703
Gary H. Loeb
Executive Vice President and Chief Legal and Compliance Officer
$615,000 $4,254,731 $5,590,211
Mark P. Brosius
Senior Vice President and Chief Manufacturing and Supply Chain Officer
$534,350 $4,520,797 $5,539,390

CEO Pay Ratio

150:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $20,997,480
Avg Employee Cost (SGA/emp): $140,121
Employees: 17,021

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
17,021
+8.8% YoY
Revenue / Employee
$591,311
Rev: $10,064,700,000
Profit / Employee
$167,793
NI: $2,856,000,000
SGA / Employee
$140,121
Avg labor cost proxy
R&D / Employee
$77,070
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
ROE 15.7% 14.7% 12.5% 12.0% 11.5% 11.2% 11.9% 12.6% 14.8% 15.8% 15.7% 16.0% 15.6% 15.9% 16.0% 16.9% 16.7% 17.2% 17.4% 18.0% 17.97%
ROA 13.8% 13.0% 11.0% 10.5% 10.0% 9.8% 10.3% 10.8% 12.7% 13.8% 13.7% 13.8% 13.6% 14.1% 14.2% 14.8% 14.5% 15.1% 15.3% 15.3% 15.28%
ROIC 21.3% 20.0% 18.7% 19.2% 19.1% 19.6% 22.5% 23.4% 20.3% 19.5% 18.6% 17.3% 16.3% 17.4% 18.5% 20.5% 21.0% 20.9% 22.1% 22.6% 22.59%
ROCE 14.7% 14.4% 13.6% 13.8% 13.7% 13.3% 13.1% 13.0% 12.8% 12.8% 12.9% 12.8% 13.7% 13.9% 14.7% 16.6% 16.8% 19.2% 19.2% 21.0% 21.04%
Gross Margin 68.4% 67.9% 67.2% 67.6% 67.1% 65.6% 66.7% 66.9% 66.2% 65.9% 68.3% 67.4% 68.0% 64.7% 66.4% 66.4% 66.4% 66.1% 67.8% 68.4% 68.37%
Operating Margin 29.0% 27.4% 26.1% 25.6% 22.5% 22.9% 26.4% 26.7% 23.3% 24.8% 28.2% 28.3% 30.4% 25.7% 30.5% 30.3% 30.2% 30.9% 33.6% 19.4% 19.44%
Net Margin 24.5% 24.6% 20.2% 20.8% 19.6% 20.9% 24.0% 23.8% 31.4% 28.8% 26.2% 27.7% 28.4% 31.0% 27.0% 28.1% 27.7% 29.6% 28.3% 17.1% 17.15%
EBITDA Margin 34.3% 33.1% 31.8% 31.4% 28.9% 28.3% 31.9% 32.9% 29.7% 30.6% 33.8% 34.0% 35.6% 31.9% 40.5% 36.7% 41.0% 41.2% 41.7% 21.9% 21.92%
FCF Margin 30.4% 24.5% 21.7% 17.6% 15.4% 15.7% 17.7% 18.3% 10.5% 8.1% 5.5% 7.4% 15.6% 20.0% 21.8% 23.6% 24.7% 26.8% 29.2% 31.1% 31.08%
OCF Margin 36.6% 31.1% 29.2% 26.5% 24.0% 25.5% 27.9% 29.5% 25.5% 23.3% 22.0% 23.1% 28.9% 31.3% 30.9% 30.8% 30.1% 31.8% 33.6% 35.3% 35.32%
ROE 3Y Avg snapshot only 16.37%
ROE 5Y Avg snapshot only 14.64%
ROA 3Y Avg snapshot only 14.04%
ROIC 3Y Avg snapshot only 18.69%
ROIC Economic snapshot only 17.12%
Cash ROA snapshot only 21.14%
Cash ROIC snapshot only 34.24%
CROIC snapshot only 30.12%
NOPAT Margin snapshot only 23.30%
Pretax Margin snapshot only 31.26%
R&D / Revenue snapshot only 12.90%
SGA / Revenue snapshot only 25.93%
SBC / Revenue snapshot only 7.21%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
P/E Ratio 77.44 67.29 50.92 49.04 71.64 69.32 85.74 69.03 67.21 72.38 76.70 79.44 81.78 72.93 75.88 58.91 71.47 55.68 45.42 48.35 53.166
P/S Ratio 23.12 18.73 12.25 11.04 15.22 14.14 18.33 15.28 16.96 19.66 21.21 22.65 22.74 20.72 21.64 16.83 20.28 15.67 12.92 12.35 13.578
P/B Ratio 11.05 9.10 6.05 5.87 8.58 8.11 10.28 8.35 9.08 10.30 10.92 11.43 11.56 10.56 11.09 9.56 11.45 9.49 7.85 8.94 9.715
P/FCF 76.05 76.57 56.44 62.86 98.84 90.24 103.63 83.29 161.21 241.48 382.81 304.07 145.68 103.46 99.21 71.24 81.95 58.52 44.24 39.74 39.736
P/OCF 63.18 60.29 42.01 41.70 63.54 55.48 65.75 51.74 66.62 84.24 96.59 97.87 78.65 66.12 70.01 54.65 67.35 49.35 38.47 34.96 34.961
EV/EBITDA 60.00 49.95 33.77 31.70 46.64 44.66 57.95 46.91 52.83 60.81 64.78 68.90 66.20 59.66 59.07 45.01 52.20 38.19 30.92 33.15 33.152
EV/Revenue 22.39 18.06 11.50 10.34 14.56 13.41 17.46 14.34 16.23 19.00 20.58 22.11 22.28 20.20 21.05 16.32 19.72 15.24 12.45 12.00 11.999
EV/EBIT 70.22 58.84 40.38 38.22 57.45 55.41 71.74 58.15 65.44 75.23 79.80 84.27 79.22 71.64 70.72 54.01 63.50 46.25 37.84 39.26 39.260
EV/FCF 73.66 73.80 53.01 58.84 94.55 85.59 98.71 78.14 154.24 233.42 371.47 296.85 142.72 100.88 96.54 69.08 79.69 56.92 42.62 38.61 38.613
Earnings Yield 1.3% 1.5% 2.0% 2.0% 1.4% 1.4% 1.2% 1.4% 1.5% 1.4% 1.3% 1.3% 1.2% 1.4% 1.3% 1.7% 1.4% 1.8% 2.2% 2.1% 2.07%
FCF Yield 1.3% 1.3% 1.8% 1.6% 1.0% 1.1% 1.0% 1.2% 0.6% 0.4% 0.3% 0.3% 0.7% 1.0% 1.0% 1.4% 1.2% 1.7% 2.3% 2.5% 2.52%
PEG Ratio snapshot only 6.012
Price/Tangible Book snapshot only 9.386
EV/OCF snapshot only 33.972
EV/Gross Profit snapshot only 17.858
Acquirers Multiple snapshot only 42.303
Shareholder Yield snapshot only 3.23%
Graham Number snapshot only $92.76
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Current Ratio 5.08 5.22 5.36 5.10 4.40 5.26 5.22 5.31 4.76 5.55 5.15 4.30 4.07 4.98 5.17 4.73 4.87 6.03 4.96 3.33 3.327
Quick Ratio 4.57 4.63 4.74 4.42 3.77 4.54 4.57 4.63 4.02 4.61 4.22 3.42 3.22 3.97 4.18 3.74 3.96 5.01 3.91 2.49 2.487
Debt/Equity 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.000
Net Debt/Equity -0.35 -0.33 -0.37 -0.38 -0.37 -0.42 -0.49 -0.52 -0.39 -0.34 -0.32 -0.27 -0.24 -0.26 -0.30 -0.29 -0.32 -0.26 -0.29 -0.25 -0.253
Debt/Assets 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.000
Debt/EBITDA 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.00 0.00 0.00 0.08 0.00 0.00 0.00 0.000
Net Debt/EBITDA -1.94 -1.87 -2.19 -2.16 -2.12 -2.43 -2.89 -3.09 -2.39 -2.10 -1.98 -1.68 -1.38 -1.53 -1.63 -1.41 -1.48 -1.08 -1.17 -0.96 -0.965
Interest Coverage — — — — — — — — — — — — — — — — — — — — —
Equity Multiplier 1.13 1.13 1.13 1.15 1.17 1.16 1.17 1.17 1.16 1.13 1.13 1.14 1.15 1.12 1.13 1.14 1.16 1.15 1.15 1.21 1.210
Cash Ratio snapshot only 1.596
Defensive Interval snapshot only 468.0 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Asset Turnover 0.46 0.47 0.46 0.47 0.47 0.48 0.48 0.49 0.50 0.51 0.50 0.48 0.49 0.50 0.50 0.52 0.51 0.54 0.54 0.60 0.598
Inventory Turnover 2.95 2.99 2.94 2.77 2.74 2.66 2.56 2.31 2.27 2.19 2.10 1.98 2.01 2.01 2.00 1.98 2.06 2.04 1.99 1.94 1.943
Receivables Turnover 8.00 7.57 7.75 7.92 7.21 7.40 7.65 7.04 6.88 7.47 7.52 6.99 7.09 7.42 8.25 7.97 7.31 7.51 7.93 7.77 7.768
Payables Turnover 17.27 15.92 14.19 13.88 15.11 14.59 12.69 12.70 14.27 13.70 12.74 12.52 14.23 12.19 13.23 12.66 15.25 11.70 13.52 13.31 13.312
DSO 46 48 47 46 51 49 48 52 53 49 49 52 51 49 44 46 50 49 46 47 47.0 days
DIO 124 122 124 132 133 137 142 158 161 167 174 185 182 182 183 184 178 179 183 188 187.9 days
DPO 21 23 26 26 24 25 29 29 26 27 29 29 26 30 28 29 24 31 27 27 27.4 days
Cash Conversion Cycle 148 147 146 151 160 161 161 181 189 189 194 208 208 201 199 201 204 197 202 207 207.4 days
Fixed Asset Turnover snapshot only 2.040
Operating Cycle snapshot only 234.9 days
Cash Velocity snapshot only 2.864
Capital Intensity snapshot only 1.671
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 31.0% 29.8% 15.5% 11.5% 9.0% 8.9% 11.7% 12.0% 14.5% 13.8% 13.6% 14.8% 17.2% 19.1% 20.8% 22.2% 20.5% 21.4% 20.7% 20.5% 20.45%
Net Income 60.7% 40.1% -11.6% -18.4% -22.4% -20.2% -0.7% 10.1% 36.0% 51.5% 46.9% 47.9% 29.2% 24.6% 24.5% 22.5% 23.0% 20.3% 20.4% 7.7% 7.66%
EPS 58.9% 38.6% -11.4% -17.0% -20.2% -17.8% 1.2% 10.8% 35.5% 49.6% 45.4% 46.1% 27.2% 23.2% 23.5% 22.8% 24.2% 21.9% 22.3% 10.8% 10.78%
FCF 51.8% 9.9% -22.1% -43.0% -44.8% -30.2% -8.9% 16.9% -21.8% -40.9% -64.4% -53.4% 73.9% 1.9% 3.8% 2.9% 91.0% 62.4% 61.6% 58.4% 58.41%
EBITDA 60.7% 45.4% 6.3% -4.8% -8.8% -9.5% -1.1% 4.9% 12.6% 18.4% 19.8% 20.6% 28.4% 29.0% 35.5% 38.1% 35.3% 43.1% 36.3% 20.2% 20.23%
Op. Income 73.5% 53.1% 5.2% -7.4% -13.4% -14.1% -4.5% 2.1% 12.0% 18.8% 20.4% 22.2% 32.9% 32.9% 34.9% 36.4% 25.4% 31.1% 31.0% 16.6% 16.62%
OCF Growth snapshot only 38.13%
Asset Growth snapshot only -0.01%
Equity Growth snapshot only -5.57%
Shares Change snapshot only -2.82%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 3Y 15.3% 15.3% 13.9% 12.9% 11.6% 11.8% 15.2% 16.7% 17.8% 17.2% 13.6% 12.8% 13.5% 13.8% 15.3% 16.3% 17.4% 18.1% 18.3% 19.1% 19.11%
Revenue 5Y 16.1% 16.2% 15.8% 15.4% 14.7% 14.3% 14.0% 13.9% 13.9% 13.7% 13.4% 13.1% 13.3% 13.6% 16.0% 17.4% 18.2% 18.4% 16.4% 16.1% 16.10%
EPS 3Y 12.4% 11.9% 5.3% 1.4% -1.2% -1.5% 8.0% 13.3% 19.8% 19.5% 9.2% 10.3% 11.2% 14.8% 22.0% 25.7% 28.9% 31.0% 30.0% 25.7% 25.71%
EPS 5Y 17.7% 14.8% 10.8% 8.2% 13.6% 11.2% 11.2% 13.7% 9.0% 11.5% 11.4% 11.0% 10.7% 12.0% 17.8% 21.1% 22.1% 20.7% 14.5% 12.8% 12.80%
Net Income 3Y 14.8% 12.8% 5.8% 1.6% -1.4% -1.8% 7.8% 12.9% 19.2% 19.2% 8.9% 9.9% 10.9% 14.6% 22.0% 25.9% 29.3% 31.4% 30.1% 24.9% 24.93%
Net Income 5Y 18.3% 16.1% 11.9% 8.8% 14.9% 11.3% 12.2% 13.7% 9.8% 11.6% 11.6% 11.3% 11.0% 12.3% 18.1% 21.1% 21.9% 20.5% 14.1% 11.9% 11.85%
EBITDA 3Y 17.4% 17.7% 13.0% 10.4% 7.2% 5.8% 13.6% 17.5% 18.2% 15.9% 8.0% 6.4% 9.7% 11.4% 17.1% 20.4% 25.1% 29.8% 30.3% 26.0% 26.02%
EBITDA 5Y 15.4% 15.2% 13.7% 12.8% 10.9% 9.2% 9.7% 9.9% 10.7% 11.8% 11.3% 11.3% 12.2% 12.6% 18.9% 22.0% 23.5% 23.5% 18.4% 14.9% 14.87%
Gross Profit 3Y 15.0% 14.9% 13.1% 12.0% 10.5% 10.6% 15.0% 16.8% 18.2% 17.1% 12.6% 11.6% 12.5% 12.9% 14.5% 15.5% 16.6% 17.7% 18.3% 19.5% 19.46%
Gross Profit 5Y 15.9% 15.8% 15.1% 14.7% 13.8% 13.1% 12.9% 12.8% 12.7% 12.7% 12.5% 12.3% 12.6% 13.0% 15.8% 17.4% 18.4% 18.3% 15.7% 15.4% 15.45%
Op. Income 3Y 14.9% 15.5% 10.6% 8.1% 4.7% 3.5% 12.9% 17.9% 18.9% 16.0% 6.6% 4.9% 8.9% 10.7% 15.7% 19.4% 23.1% 27.5% 28.6% 24.8% 24.81%
Op. Income 5Y 14.0% 13.6% 11.9% 10.8% 8.4% 6.4% 6.9% 7.2% 8.1% 9.5% 9.2% 9.5% 11.3% 11.8% 18.5% 22.2% 22.9% 22.2% 16.4% 13.0% 12.95%
FCF 3Y 20.9% 14.6% 8.7% 1.0% -6.5% -5.7% 2.7% 8.3% -13.1% -23.2% -36.8% -32.3% -9.1% 6.5% 15.5% 28.3% 37.5% 41.2% 39.8% 42.0% 41.98%
FCF 5Y 11.9% 8.1% 7.5% 2.3% 0.1% 0.1% 2.7% 4.7% -5.3% -9.1% -16.1% -10.9% 2.1% 7.7% 12.9% 18.1% 16.9% 16.6% 14.2% 13.8% 13.81%
OCF 3Y 21.3% 14.5% 10.0% 5.4% -2.3% 0.4% 6.7% 12.8% 6.9% 2.0% -4.7% -5.4% 4.9% 14.2% 17.6% 22.2% 26.7% 27.0% 25.9% 26.4% 26.43%
OCF 5Y 14.9% 11.3% 10.8% 7.3% 5.4% 6.7% 9.2% 11.7% 9.2% 6.9% 4.9% 5.6% 8.6% 11.0% 13.0% 16.0% 15.3% 15.9% 14.0% 13.7% 13.73%
Assets 3Y 20.0% 18.4% 17.1% 13.2% 10.1% 9.7% 11.2% 11.5% 11.4% 11.1% 10.6% 11.1% 11.6% 12.0% 13.7% 13.4% 16.7% 15.5% 14.5% 9.6% 9.56%
Assets 5Y 15.9% 23.3% 21.2% 18.6% 17.6% 15.2% 15.2% 15.0% 14.5% 14.0% 14.3% 14.2% 14.1% 14.2% 14.8% 12.8% 13.1% 11.7% 11.2% 8.4% 8.39%
Equity 3Y 21.4% 20.0% 18.4% 14.0% 10.0% 9.6% 10.7% 10.5% 10.9% 11.1% 10.6% 10.8% 11.2% 12.1% 13.9% 13.7% 17.3% 15.9% 15.2% 8.4% 8.43%
Book Value 3Y 18.9% 19.1% 17.7% 13.7% 10.3% 9.9% 10.8% 10.9% 11.4% 11.3% 11.0% 11.2% 11.6% 12.3% 13.9% 13.6% 16.9% 15.5% 15.1% 9.1% 9.11%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue Stability 0.92 0.93 0.98 0.96 0.94 0.94 0.98 0.97 0.95 0.96 0.99 0.99 0.97 0.96 0.97 0.97 0.98 0.97 0.95 0.94 0.938
Earnings Stability 0.73 0.82 0.80 0.59 0.52 0.54 0.63 0.54 0.47 0.55 0.63 0.56 0.62 0.68 0.76 0.79 0.85 0.87 0.81 0.81 0.809
Margin Stability 0.97 0.98 0.98 0.98 0.97 0.98 0.98 0.98 0.97 0.98 0.98 0.98 0.98 0.98 0.99 0.99 0.99 1.00 0.99 0.98 0.984
Rev. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.84 0.95 0.93 0.91 0.92 1.00 0.96 0.86 0.50 0.81 0.81 0.88 0.90 0.90 0.91 0.91 0.92 0.92 0.97 0.969
Earnings Smoothness 0.53 0.67 0.88 0.80 0.75 0.78 0.99 0.90 0.70 0.59 0.62 0.61 0.75 0.78 0.78 0.80 0.79 0.82 0.82 0.93 0.926
ROE Trend 0.01 -0.00 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.02 0.02 0.02 0.01 0.02 0.01 0.03 0.02 0.03 0.03 0.03 0.032
Gross Margin Trend 0.02 0.01 0.00 -0.00 -0.00 -0.01 -0.02 -0.02 -0.02 -0.01 -0.01 -0.00 0.01 0.00 -0.00 -0.00 -0.01 -0.00 -0.00 0.00 0.005
FCF Margin Trend 0.04 -0.03 -0.07 -0.11 -0.13 -0.11 -0.09 -0.08 -0.12 -0.12 -0.14 -0.11 0.03 0.08 0.10 0.11 0.12 0.13 0.16 0.16 0.155
Sustainable Growth Rate 15.7% 14.7% 12.5% 12.0% 11.5% 11.2% 11.9% 12.6% 14.8% 15.8% 15.7% 16.0% 15.6% 15.9% 16.0% 16.9% 16.7% 17.2% 17.4% 18.0% 17.97%
Internal Growth Rate 16.0% 15.0% 12.4% 11.8% 11.1% 10.9% 11.5% 12.2% 14.5% 16.0% 15.9% 16.0% 15.7% 16.5% 16.5% 17.4% 16.9% 17.9% 18.1% 18.0% 18.04%
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
OCF/Net Income 1.23 1.12 1.21 1.18 1.13 1.25 1.30 1.33 1.01 0.86 0.79 0.81 1.04 1.10 1.08 1.08 1.06 1.13 1.18 1.38 1.383
FCF/OCF 0.83 0.79 0.74 0.66 0.64 0.61 0.63 0.62 0.41 0.35 0.25 0.32 0.54 0.64 0.71 0.77 0.82 0.84 0.87 0.88 0.880
FCF/Net Income snapshot only 1.217
OCF/EBITDA snapshot only 0.976
CapEx/Revenue 6.2% 6.6% 7.5% 8.9% 8.6% 9.8% 10.2% 11.2% 14.9% 15.2% 16.4% 15.7% 13.3% 11.3% 9.1% 7.2% 5.4% 5.0% 4.4% 4.2% 4.25%
CapEx/Depreciation snapshot only 0.754
Accruals Ratio -0.03 -0.02 -0.02 -0.02 -0.01 -0.02 -0.03 -0.04 -0.00 0.02 0.03 0.03 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.03 -0.06 -0.059
Sloan Accruals snapshot only -0.076
Cash Flow Adequacy snapshot only 8.320
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 6.5% 42.3% 1.2% 2.0% 2.2% 1.6% 89.1% 23.2% 3.3% 3.2% 3.0% 0.0% 0.0% 6.9% 76.2% 80.4% 1.1% 1.1% 1.6% 1.56%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.1% 0.8% 2.4% 2.8% 3.1% 1.9% 1.3% 0.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 1.3% 1.1% 2.1% 2.5% 3.2% 3.23%
Net Buyback Yield -0.2% -0.1% 0.7% 2.3% 2.8% 3.1% 1.9% 1.1% 0.2% -0.2% -0.2% -0.2% -0.2% -0.2% -0.1% 1.1% 1.0% 1.9% 2.2% 3.0% 2.98%
Total Shareholder Return -0.2% -0.1% 0.7% 2.3% 2.8% 3.1% 1.9% 1.1% 0.2% -0.2% -0.2% -0.2% -0.2% -0.2% -0.1% 1.1% 1.0% 1.9% 2.2% 3.0% 2.98%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Tax Burden (NI/EBT) 0.90 0.89 0.83 0.83 0.82 0.81 0.83 0.83 0.92 0.96 0.94 0.94 0.87 0.88 0.87 0.87 0.86 0.83 0.82 0.82 0.817
Interest Burden (EBT/EBIT) 1.04 1.02 1.02 1.01 1.02 1.04 1.06 1.09 1.11 1.12 1.14 1.15 1.14 1.14 1.10 1.09 1.06 1.03 1.05 1.02 1.023
EBIT Margin 0.32 0.31 0.28 0.27 0.25 0.24 0.24 0.25 0.25 0.25 0.26 0.26 0.28 0.28 0.30 0.30 0.31 0.33 0.33 0.31 0.306
Asset Turnover 0.46 0.47 0.46 0.47 0.47 0.48 0.48 0.49 0.50 0.51 0.50 0.48 0.49 0.50 0.50 0.52 0.51 0.54 0.54 0.60 0.598
Equity Multiplier 1.14 1.13 1.13 1.14 1.15 1.14 1.15 1.16 1.17 1.15 1.15 1.15 1.15 1.13 1.13 1.14 1.15 1.14 1.14 1.18 1.176
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
EPS (Diluted TTM) $4.64 $4.48 $3.94 $3.82 $3.70 $3.69 $3.99 $4.23 $5.02 $5.51 $5.80 $6.18 $6.38 $6.79 $7.16 $7.59 $7.92 $8.28 $8.76 $8.41 $8.41
Book Value/Share $32.53 $33.15 $33.20 $31.94 $30.93 $31.51 $33.25 $35.01 $37.15 $38.73 $40.74 $42.96 $45.16 $46.92 $49.01 $46.79 $49.46 $48.57 $50.68 $45.47 $46.18
Tangible Book/Share $31.40 $32.04 $32.06 $30.82 $29.81 $30.41 $32.14 $32.25 $36.07 $37.67 $39.70 $41.93 $44.14 $45.91 $48.01 $45.79 $48.40 $46.38 $48.51 $43.32 $43.32
Revenue/Share $15.54 $16.10 $16.39 $16.97 $17.43 $18.06 $18.65 $19.13 $19.89 $20.30 $20.98 $21.69 $22.95 $23.90 $25.12 $26.57 $27.93 $29.41 $30.78 $32.93 $33.17
FCF/Share $4.72 $3.94 $3.56 $2.98 $2.68 $2.83 $3.30 $3.51 $2.09 $1.65 $1.16 $1.62 $3.58 $4.79 $5.48 $6.28 $6.91 $7.88 $8.99 $10.23 $10.31
OCF/Share $5.69 $5.00 $4.78 $4.50 $4.18 $4.60 $5.20 $5.65 $5.06 $4.74 $4.61 $5.02 $6.64 $7.49 $7.76 $8.18 $8.41 $9.34 $10.34 $11.63 $11.72
Cash/Share $11.52 $10.90 $12.22 $11.98 $11.53 $13.18 $16.23 $18.08 $14.58 $13.32 $13.18 $11.67 $11.03 $12.37 $14.63 $13.57 $16.47 $12.64 $14.55 $11.50 $11.58
EBITDA/Share $5.80 $5.82 $5.58 $5.54 $5.44 $5.42 $5.62 $5.85 $6.11 $6.34 $6.66 $6.96 $7.72 $8.09 $8.95 $9.63 $10.55 $11.74 $12.39 $11.92 $11.92
Debt/Share $0.24 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.40 $0.00 $0.00 $0.00 $0.84 $0.00 $0.00 $0.00 $0.00
Net Debt/Share $-11.28 $-10.90 $-12.22 $-11.98 $-11.53 $-13.18 $-16.23 $-18.08 $-14.58 $-13.32 $-13.18 $-11.67 $-10.63 $-12.37 $-14.63 $-13.57 $-15.63 $-12.64 $-14.55 $-11.50 $-11.50
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 28.442
Altman Z-Prime snapshot only 50.448
Piotroski F-Score 6 5 5 5 6 6 5 7 6 6 5 5 6 5 6 7 7 8 7 7 7
Beneish M-Score -2.13 -2.05 -2.36 -2.43 -2.47 -2.71 -2.70 -2.67 -2.35 -2.16 -2.01 -1.81 -2.17 -2.28 -2.28 -2.45 -2.40 -2.54 -2.41 -2.68 -2.681
Ohlson O-Score snapshot only -13.064
ROIC (Greenblatt) snapshot only 30.58%
Net-Net WC snapshot only $14.78
EVA snapshot only $1503601182.65
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Credit Rating snapshot only AA
Credit Score 90.44 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 91.74 89.00 89.00 89.00 92.49 89.00 89.00 89.00 89.000
Credit Grade snapshot only 3
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 80.000
Industry Credit Rank snapshot only 86
Sector Credit Rank snapshot only 81

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms